시장보고서
상품코드
1663503

세계의 혈관내 치료 기기 시장 : 제품별, 시술별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Endovascular Treatment Devices Market, By Product, By Procedure, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 316 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

혈관내 치료 기기 시장 규모는 2024년 34억 5,033만 달러로 평가되었고, 2025-2032년간 연평균 복합 성장률(CAGR) 9.50%로 성장할 것으로 예상됩니다.

혈관내 치료 기기 시장 역학

혈관 질환 증가

말초동맥질환(PAD), 대동맥류, 정맥혈전색전증(VTE)과 같은 혈관질환은 인구 고령화, 좌식 생활습관, 비만, 고혈압, 당뇨병과 같은 위험요인으로 인해 더욱 확산되고 있습니다. 세계보건기구(WHO)에 따르면 혈관 질환을 포함한 심혈관계 질환으로 인한 사망자 수는 연간 약 1,790만 명으로 전 세계 사망자 수의 32%를 차지합니다. 혈류를 회복하고 생명을 위협하는 합병증을 예방하기 위해 효과적인 중재를 필요로 하는 환자가 증가함에 따라 첨단 치료 옵션에 대한 수요가 증가하고 있습니다. 스텐트 그라프트, 풍선 카테터, 혈전 제거 시스템과 같은 혈관 내 장치는 이러한 질환을 관리할 수 있는 최소 침습적 솔루션을 제공합니다. 이는 기존의 개복 수술에 비해 안전하고 효율적인 대안을 제공하여 입원 기간, 회복 시간, 수술 후 합병증 위험을 줄여줍니다. 또한, 의료 인프라를 개선하고 혈관 질환의 조기 진단 및 치료에 대한 인식을 높이기 위한 정부의 이니셔티브는 시장 확대를 더욱 촉진하고 있습니다. 예를 들어, 심혈관 위험 감소를 목표로 하는 국민 건강 캠페인과 최신 혈관 치료 기술의 통합이 성장을 가속하고 있습니다.

혈관내 치료 기기 시장 : 주요 고찰

  • 리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 9.50%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.
  • 제품별로는 스텐트가 2024년 가장 큰 시장 점유율을 보였습니다.
  • 최종 사용자별로는 병원이 2024년 주요 부문입니다.
  • 지역별로 보면 북미가 2024년 주요 수익 창출 시장으로 부상했습니다.

혈관내 치료 기기 시장 : 세분화 분석

혈관내 치료 기기 세계 시장은 제품, 시술, 최종 사용자, 지역별로 세분화됩니다.

시장은 제품별로 스텐트, 풍선 카테터, 하대정맥 필터의 세 가지로 분류됩니다. 스텐트는 혈류를 효율적으로 회복시키고 재협착의 위험을 감소시켜 동맥 폐색 치료에 널리 사용되기 때문에 시장을 독점하고 있습니다. 또한, 약물 용출성 스텐트 및 생체 흡수성 스텐트의 발전은 장기적인 치료 결과를 개선하여 시장 주도권을 유지하는 원동력이 되고 있습니다.

시장은 최종 사용자별로 병원, 외래수술센터(ASC), 전문 클리닉의 세 가지로 분류됩니다. 병원은 첨단 의료 인프라, 전문 혈관치료실, 복잡한 혈관 내 치료에 필요한 숙련된 전문가를 갖추고 있어 시장을 독점하고 있습니다. 또한, 환자 유입이 많고, 수술 후 관리 시설을 이용할 수 있기 때문에 병원이 혈관내시경을 위해 선택되고 있습니다.

혈관내 치료 기기 시장 : 지역별 분석

북미는 높은 혈관 질환 유병률, 첨단 의료 시스템, 최소침습적 시술의 보급으로 세계 시장을 선도하고 있습니다. 미국심장협회에 따르면, 심혈관 질환은 여전히 미국의 주요 사망 원인으로 혁신적인 혈관 내 치료 솔루션에 대한 수요를 더욱 증가시키고 있습니다. 또한, 유리한 상환 정책과 지속적인 제품 발전이 이 지역의 우위를 강화하고 있습니다. 유럽은 고령화, 의료비 지출 증가, 심혈관 질환 관리를 촉진하기 위한 정부의 이니셔티브에 힘입어 큰 시장 점유율을 차지하고 있습니다. 독일, 영국, 프랑스와 같은 국가들은 탄탄한 의료 시스템과 의료기기의 기술적 진보로 인해 큰 기여를 하고 있습니다. 아시아태평양은 의료에 대한 인식 증가, 말초동맥질환 환자 증가, 의료 인프라 개선 등으로 인해 가장 빠른 성장이 예상됩니다. 중국, 인도, 일본 등의 국가에서는 급속한 도시화, 라이프스타일의 변화, 노인 인구 증가가 시장 확대에 기여하고 있습니다. 또한, 현대식 의료 시설에 대한 정부의 투자와 의료 접근성 개선이 이 지역 수요를 촉진하고 있습니다.

혈관내 치료 기기 시장 : 경쟁 구도

혈관내 치료 기기 시장의 경쟁 환경은 기술 혁신, 제품 차별화, 전략적 제휴에 초점을 맞춘 주요 업체들 간의 치열한 적대적 관계로 특징지을 수 있습니다. 각 업체들은 약물 용출성 스텐트, 생체 흡수성 스텐트, 첨단 색전 방지 시스템, 신규 혈전 제거 장치 등 안전성, 유효성, 내구성이 개선된 차세대 장치를 도입하기 위해 연구개발에 많은 투자를 하고 있습니다. 시장 진출기업들은 또한 다양한 혈관 질환에 대한 저침습적 솔루션에 대한 수요 증가에 대응하기 위해 포트폴리오를 확장하고 있습니다. 전략적 파트너십, 합병 및 인수는 시장에서의 입지를 강화하고, 기술 발전을 촉진하며, 지리적 범위를 확대하기 위한 일반적인 전술입니다. 또한 각 기업들은 엄격한 안전 기준을 충족하고 세계 의료 규제를 준수하면서 경쟁력을 확보하기 위해 규제 당국의 승인과 임상시험에 중점을 두고 있으며, AI 기반 진단 및 스마트 혈관 내 치료 기술의 채택이 증가함에 따라 정확도 향상과 개인 맞춤형 치료의 기회를 창출하고 있습니다. 기회를 창출하고 있습니다. 경쟁력 있는 가격 책정, 탄탄한 유통망, 사후 지원도 시장 점유율 유지에 중요한 역할을 하고 있습니다. 첨단 혈관 치료 솔루션에 대한 수요가 증가함에 따라 경쟁이 심화될 것으로 예상되며, 이는 이 역동적인 분야에서 지속적인 기술 혁신과 환자 결과 개선을 촉진할 것입니다.

목차

제1장 혈관내 치료 기기 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 혈관내 치료 기기 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 혈관내 치료 기기 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 혈관내 치료 기기 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아 우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 혈관내 치료 기기 시장 구도

  • 혈관내 치료 기기 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 혈관내 치료 기기 시장 : 제품별

  • 개요
    • 부문별 점유율 분석 : 제품별
    • 스텐트
    • 풍선 카테터
    • 하대정맥 필터
    • 기타

제8장 혈관내 치료 기기 시장 : 시술별

  • 개요
    • 부문별 점유율 분석 : 시술별
    • 혈관 성형술
    • 동맥류 수복술
    • 혈전 제거술
    • 기타

제9장 혈관내 치료 기기 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 병원
    • 외래수술센터(ASC)
    • 전문 클리닉
    • 기타

제10장 혈관내 치료 기기 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 혈관내 치료 기기 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Johnson &Johnson Services, Inc.
    • Terumo Corporation
    • Cook Group Incorporated
    • Edwards Lifesciences Corporation
    • WL Gore &Associates, Inc.
    • Philips Healthcare
    • Siemens Healthineers
    • Cardinal Health
    • Stryker Corporation
    • Baxter International Inc.
    • Asahi Intecc Co., Ltd.
    • Others

제12장 AnalystView의 전방위적 분석

LSH 25.03.18

REPORT HIGHLIGHT

Endovascular Treatment Devices Market size was valued at US$ 3,450.33 Million in 2024, expanding at a CAGR of 9.50% from 2025 to 2032.

Endovascular treatment devices are medical instruments used in minimally invasive procedures to treat various vascular diseases by accessing blood vessels through small incisions or punctures. These devices include stents, balloon catheters, embolic protection devices, and thrombectomy systems, which are essential for managing conditions like aneurysms, arterial blockages, and venous thromboembolism. Unlike traditional open surgeries, endovascular treatments offer a less invasive alternative, reducing patient trauma, hospital stays, and recovery times. The need for endovascular treatment devices arises from the growing prevalence of cardiovascular and peripheral vascular diseases driven by aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes. These devices enable precision-targeted interventions, improving clinical outcomes and patient safety. For example, stent grafts reinforce weakened blood vessels, preventing potentially fatal ruptures, while thrombectomy devices remove life-threatening blood clots with minimal risk. Their importance lies in transforming the management of complex vascular conditions. Endovascular procedures significantly reduce morbidity and mortality rates compared to conventional surgeries. They also lower healthcare costs by minimizing postoperative complications and facilitating faster recovery. Furthermore, technological advancements in device design and materials continue to enhance the effectiveness and durability of treatments, driving the adoption of endovascular solutions as a cornerstone in modern vascular care.

Endovascular Treatment Devices Market- Market Dynamics

Increasing prevalence of vascular diseases

Vascular conditions, including peripheral artery disease (PAD), aortic aneurysms, and venous thromboembolism (VTE), are becoming more widespread due to aging populations, sedentary lifestyles, and risk factors such as obesity, hypertension, and diabetes. According to the World Health Organization (WHO), cardiovascular diseases, which include vascular disorders, account for nearly 17.9 million deaths annually, representing 32% of all global deaths. A growing number of patients require effective interventions to restore blood flow and prevent life-threatening complications, increasing the demand for advanced treatment options. Endovascular devices, such as stent grafts, balloon catheters, and thrombectomy systems, offer minimally invasive solutions to manage these conditions. They provide a safer and more efficient alternative to traditional open surgeries, reducing hospital stays, recovery times, and the risk of postoperative complications. Furthermore, government initiatives to improve healthcare infrastructure and raise awareness about early diagnosis and treatment of vascular diseases further support market expansion. For example, national health campaigns targeting cardiovascular risk reduction and the integration of modern vascular care technologies are fostering growth.

Endovascular Treatment Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.50% over the forecast period (2025-2032)
  • Based on Product segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Hospitals was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Endovascular Treatment Devices Market- Segmentation Analysis:

The Global Endovascular Treatment Devices Market is segmented on the basis of Product, Procedure, End-User and Region.

The market is divided into three categories based on Product: Stents, Balloon Catheters and Inferior Vena Cava Filters. Stents dominate the market due to their widespread use in treating arterial blockages by restoring blood flow efficiently and reducing the risk of restenosis. Additionally, advancements in drug-eluting and bioresorbable stents enhance long-term outcomes, driving their continued market leadership.

The market is divided into three categories based on End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics. Hospitals dominate the market because they are equipped with advanced medical infrastructure, specialized vascular care units, and skilled professionals required for complex endovascular procedures. Additionally, the higher patient inflow and availability of post-operative care facilities make hospitals the preferred choice for vascular treatments.

Endovascular Treatment Devices Market- Geographical Insights

North America leads the global market, driven by a high incidence of vascular diseases, advanced healthcare systems, and widespread adoption of minimally invasive procedures. According to the American Heart Association, cardiovascular diseases remain a leading cause of death in the United States, further boosting the demand for innovative endovascular solutions. Additionally, favorable reimbursement policies and continuous product advancements strengthen the region's dominance. Europe holds a substantial market share, supported by an aging population, increased healthcare spending, and government initiatives promoting cardiovascular disease management. Countries like Germany, the United Kingdom, and France contribute significantly due to their robust healthcare systems and technological advancements in medical devices. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare awareness, increasing cases of peripheral artery diseases, and improvements in healthcare infrastructure. Rapid urbanization, lifestyle changes, and a growing elderly population in countries like China, India, and Japan further contribute to market expansion. Moreover, government investments in modern healthcare facilities and increasing access to medical treatments are propelling demand in this region.

Endovascular Treatment Devices Market- Competitive Landscape:

The competitive landscape of the endovascular treatment devices market is characterized by intense rivalry among key players focusing on innovation, product differentiation, and strategic collaborations. Companies are investing heavily in research and development to introduce next-generation devices with improved safety, efficacy, and durability, such as drug-eluting and bioresorbable stents, advanced embolic protection systems, and novel thrombectomy devices. Market participants are also expanding their portfolios to cater to the growing demand for minimally invasive solutions across diverse vascular conditions. Strategic partnerships, mergers, and acquisitions are common tactics to enhance market presence, drive technological advancements, and expand geographic reach. Additionally, players are emphasizing regulatory approvals and clinical trials to gain a competitive edge while meeting stringent safety standards and ensuring compliance with global healthcare regulations. The increasing adoption of AI-driven diagnostics and smart endovascular technologies is shaping the market, creating opportunities for enhanced precision and personalized treatment. Competitive pricing, robust distribution networks, and post-sales support also play critical roles in maintaining market share. As the demand for advanced vascular treatment solutions grows, the competitive intensity is expected to rise, fostering continuous innovation and improved patient outcomes in this dynamic sector.

Recent Developments:

  • In June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., a company specializing in devices for transcarotid artery revascularization (TCAR), a minimally invasive procedure aimed at preventing strokes in patients with carotid artery disease.
  • In July 2024, Sensome signed an exclusive distribution agreement with Cosmotec in Japan for its clot-sensing guidewire. This partnership allows Cosmotec to commercialize Sensome's innovative technology, which is designed to detect blood clots in real time during endovascular procedures, improving clinical decision-making and patient outcomes. The agreement marks an important step in Sensome's expansion into the Japanese market, enhancing access to its cutting-edge medical devices.
  • In November 2024, Solaris Endovascular, Inc. has launched in the U.S. to develop solutions for dialysis access in end-stage kidney disease and peripheral artery disease treatment. Its flagship product, the Solaris SX vascular stent graft, aims to reduce restenosis and improve patency with advanced technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Cook Group Incorporated
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Cardinal Health
  • Stryker Corporation
  • Baxter International Inc.
  • Asahi Intecc Co., Ltd.
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Balloon Catheters
  • Inferior Vena Cava Filters
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Aneurysm Repair
  • Thrombectomy
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Endovascular Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Endovascular Treatment Devices Market Snippet by Product
    • 2.1.2. Endovascular Treatment Devices Market Snippet by Procedure
    • 2.1.3. Endovascular Treatment Devices Market Snippet by End-User
    • 2.1.4. Endovascular Treatment Devices Market Snippet by Country
    • 2.1.5. Endovascular Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Endovascular Treatment Devices Key Market Trends

  • 3.1. Endovascular Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Endovascular Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Endovascular Treatment Devices Market Opportunities
  • 3.4. Endovascular Treatment Devices Market Future Trends

4. Endovascular Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Endovascular Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Endovascular Treatment Devices Market Landscape

  • 6.1. Endovascular Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Endovascular Treatment Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Balloon Catheters
    • 7.1.4. Inferior Vena Cava Filters
    • 7.1.5. Others

8. Endovascular Treatment Devices Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Aneurysm Repair
    • 8.1.4. Thrombectomy
    • 8.1.5. Others

9. Endovascular Treatment Devices Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Others

10. Endovascular Treatment Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Endovascular Treatment Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Endovascular Treatment Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Endovascular Treatment Devices Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Endovascular Treatment Devices Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Endovascular Treatment Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Endovascular Treatment Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Medtronic plc
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Johnson & Johnson Services, Inc.
    • 11.2.5. Terumo Corporation
    • 11.2.6. Cook Group Incorporated
    • 11.2.7. Edwards Lifesciences Corporation
    • 11.2.8. W. L. Gore & Associates, Inc.
    • 11.2.9. Philips Healthcare
    • 11.2.10. Siemens Healthineers
    • 11.2.11. Cardinal Health
    • 11.2.12. Stryker Corporation
    • 11.2.13. Baxter International Inc.
    • 11.2.14. Asahi Intecc Co., Ltd.
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제